ArticlePloS one2026
Serum IgA and IgM levels in hemochromatosis probands with HFE p.C282Y homozygosity.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHFE p.C282Y (rs1800562) homozygotes, including those with normal iron phenotypes, have increased risks of infection and death from infections, although serum IgA and IgM in cohorts of adults with p.C282Y homozygosity are not reported.
methodsWe compiled serum IgA and IgM levels at diagnosis of hemochromatosis in probands with p.C282Y homozygosity, investigated associations of IgA and IgM with clinical characteristics, blood count measures, and iron phenotypes, and compared mean IgA and IgM of probands with combined/weighted means of published adult European cohorts not selected for hemochromatosis.
resultsThere were 73 probands (36 men, 37 women; mean age 51 ± 13 y). Fifty probands (68.5%) had human leukocyte antigen (HLA)-A*03. Mean IgA ± standard deviation [95% confidence interval] was 2.11 ± 1.06 g/L [1.87, 2.35]. Mean IgM was 1.11 ± 0.75 g/L [0.94, 1.28]. IgM was inversely associated with age (Pearson's r73 = -0.2733; p = 0.019). A multiple regression on IgA revealed no significant association with other characteristics. A regression on IgM revealed one positive association (daily alcohol intake; p = 0.036) and one negative association (age; p = 0.016). Mean IgA of male and female probands and corresponding mean IgA of Europeans in two cohorts (918 men, 458 women) did not differ significantly. Mean IgM of probands was lower than the mean IgM of Europeans in four cohorts (men 1.03 ± 0.84 g/L vs. 1.35 ± 0.55 g/L (n = 1084), respectively (p < 0.001); women 1.18 ± 0.67 g/L vs. 1.57 ± 0.68 g/L (n = 622), respectively (p < 0.001)).
conclusionsThere is no significant association of serum IgA in HFE p.C282Y homozygotes with the clinical and laboratory characteristics we studied. Serum IgM levels are positively associated with daily alcohol intake, are inversely associated with age, and are lower than those of Europeans not selected for hemochromatosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.